Skip to content
Find a Provider
Ruth B. Schneider, M.D.

Ruth B. Schneider, M.D.

she/her/hers

Neurology

UR Medicine Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Accepting New Patients

Contact

Appointment (585) 341-7500

Locations

Movement Disorders Clinic

919 Westfall Road, Suite 100
Rochester, NY 14618

(585) 341-7500 Get Directions

About Me

Dr. Schneider is a board-certified neurologist with expertise in movement disorders. She graduated from Brown University in 2006 and received her MD from the University of Rochester School of Medicine and Dentistry in 2010. She completed her neurology residency in 2014 and a movement disorders fell...
Dr. Schneider is a board-certified neurologist with expertise in movement disorders. She graduated from Brown University in 2006 and received her MD from the University of Rochester School of Medicine and Dentistry in 2010. She completed her neurology residency in 2014 and a movement disorders fellowship in 2015, both at the University of Rochester. She joined the faculty in 2015 and specializes in the care of patients with movement disorders, including Parkinson's disease, Huntington's disease, and essential tremor. She is the Director of our Huntington's Disease Society of America Center of Excellence. Her research focuses on the development of digital measures of disease, participant-centered remote research designs, and the neuropsychiatric manifestations of Parkinson's disease.

Faculty Appointments

Associate Professor - Department of Neurology, Movement Disorders (SMD)

Associate Professor - Center for Health and Technology - Joint

Credentials

Residency & Fellowship

Fellowship, Movement Disorders, University of Rochester Medical Center. 2014 - 2015

Residency, Neurology, University of Rochester Medical Center. 2011 - 2014

Internship, Internal Medicine, University of Rochester Medical Center. 2010 - 2011

Education

MD | University of Rochester School of Medicine/Dentistry. 2010

Awards

Women Leading in Neurology Program. 2021 - 2022

Research

Clinical Trials

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in Subjects with Parkinson's Disease with a Pathogenic Variant in the Glucocerebrosidase (GBA1) Gene ,

Lead Researcher: Ruth Schneider

This is a 2-part (Part A [Genetic Screening] and Part B [Double-Blind Treatment]) study to test if 2 fixed dose levels of BIA 28-6156 (10 and 60 mg/day) delays progression of Parkinson's Disease in approximately 237 subjects with genetically confirme...

The Parkinson's Progression Markers Initiative (PPMI) 2.0 Clinical -Establishing a Deeply Phenotyped PD Cohort

Lead Researcher: Ruth Schneider

The Parkinson Progression Marker Initiative 2.0 (PPMI 2.0) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of P...

Publications

Journal Articles

Conventionvs. Innovation I: Digital technology will replace clinic-based care in Parkinson disease.

Schneider RB, Phillips O, Kalia L

Parkinsonism & related disorders.. 2024 February 29 :106067. Epub 02/29/2024.

Untangling Depression, Antidepressant Use, and Symptom Severity: A Commentary on "The Association of Antidepressant Use and Impulse Control Disorder in Parkinson's Disease".

Hitchins A, Schneider RB

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.. 2024 January 26 Epub 01/26/2024.

The Importance of Digital Health Literacy in an Evolving Parkinson's Disease Care System.

Esper CD, Valdovinos BY, Schneider RB

Journal of Parkinson's disease.. 2024 January 13 Epub 01/13/2024.

Real or imagined: We need a new scale for psychosis in Parkinson's disease.

Pontone GM, Mills KA, Dobkin RD, Hinkle JT, Nirenberg MJ, Schneider RB,

Parkinsonism & related disorders.. 2024 January 11 :106004. Epub 01/11/2024.

Digital assessment of speech in Huntington disease.

Nunes AS, Pawlik M, Mishra RK, Waddell E, Coffey M, Tarolli CG, Schneider RB, Dorsey ER, Vaziri A, Adams JL

Frontiers in neurology. 2024 15 :1310548. Epub 01/23/2024.

Using AI to measure Parkinson's disease severity at home.

Islam MS, Rahman W, Abdelkader A, Lee S, Yang PT, Purks JL, Adams JL, Schneider RB, Dorsey ER, Hoque E

NPJ digital medicine.. 2023 August 236 (1):156. Epub 08/23/2023.

Moving beyond alerts: Electronic health record strategies to improve inpatient Parkinson's disease care.

Kadura S, Schneider RB

Parkinsonism & related disorders.. 2023 August 22 :105819. Epub 08/22/2023.

Minor Phenomena in Parkinson's Disease-Prevalence, Associations, and Risk of Developing Psychosis.

Schneider RB, Auinger P, Dobkin RD, Mills KA, Kulick-Soper CV, Myers TL, Korell M, Pontone GM, Nirenberg MJ

Journal of geriatric psychiatry and neurology.. 2023 August 5 :8919887231195220. Epub 08/05/2023.

Trichloroethylene: An Invisible Cause of Parkinson's Disease?

Dorsey ER, Zafar M, Lettenberger SE, Pawlik ME, Kinel D, Frissen M, Schneider RB, Kieburtz K, Tanner CM, De Miranda BR, Goldman SM, Bloem BR

Journal of Parkinson's disease.. 2023 13 (2):203-218. Epub 1900 01 01.

A Remote Longitudinal Observational Study of Individuals at Genetic Risk for Parkinson Disease: Baseline Results.

Jensen-Roberts S, Myers TL, Auinger P, Cannon P, Rowbotham HM, Coker D, Chanoff E, Soto J, Pawlik M, Amodeo K, Sharma S, Valdovinos B, Wilson R, Sarkar A, McDermott MP, Alcalay RN, Biglan K, Kinel D, Tanner C, Winter-Evans R, Augustine EF, Holloway RG, Dorsey ER, Schneider RB

Neurology. Genetics.. 2022 October 8 (5):e200008. Epub 08/11/2022.

Monitoring gait at home with radio waves in Parkinson's disease: A marker of severity, progression, and medication response.

Liu Y, Zhang G, Tarolli CG, Hristov R, Jensen-Roberts S, Waddell EM, Myers TL, Pawlik ME, Soto JM, Wilson RM, Yang Y, Nordahl T, Lizarraga KJ, Adams JL, Schneider RB, Kieburtz K, Ellis T, Dorsey ER, Katabi D

Science translational medicine.. 2022 September 2114 (663):eadc9669. Epub 09/21/2022.

Recommendations for Virtual Administration of the PSP Rating Scale.

Wills AM, Golbe LI, Lang AE, Xie T, Dale ML, Espay A, Tartaglia MC, Fox SH, Parashos SA, McFarland NR, Schneider RB, Rodriguez-Porcel F, Gunzler SA, Pantelyat A

Movement disorders : official journal of the Movement Disorder Society.. 2022 July 10 Epub 07/10/2022.

Moving Forward from the COVID-19 Pandemic: Needed Changes in Movement Disorders Care and Research.

Valdovinos BY, Modica JS, Schneider RB

Current neurology and neuroscience reports.. 2022 February 2 Epub 02/02/2022.

Change in the Parkinson Anxiety Scale correlates with change in other clinical measures of anxiety over time.

Schneider RB, Auinger P, Tarolli CG, Iourinets J, Gil Díaz MC, Richard IH

Clinical parkinsonism & related disorders.. 2022 6 :100126. Epub 12/13/2021.

Recruitment for Remote Decentralized Studies in Parkinson's Disease.

Myers TL, Augustine EF, Baloga E, Daeschler M, Cannon P, Rowbotham H, Chanoff E, , Jensen-Roberts S, Soto J, Holloway RG, Marras C, Tanner CM, Ray Dorsey E, Schneider RB

Journal of Parkinson's disease.. 2021 October 31 Epub 10/31/2021.

Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial.

, Schwarzschild MA, Ascherio A, Casaceli C, Curhan GC, Fitzgerald R, Kamp C, Lungu C, Macklin EA, Marek K, Mozaffarian D, Oakes D, Rudolph A, Shoulson I, Videnovic A, Scott B, Gauger L, Aldred J, Bixby M, Ciccarello J, Gunzler SA, Henchcliffe C, Brodsky M, Keith K, Hauser RA, Goetz C, LeDoux MS, Hinson V, Kumar R, Espay AJ, Jimenez-Shahed J, Hunter C, Christine C, Daley A, Leehey M, de Marcaida JA, Friedman JH, Hung A, Bwala G, Litvan I, Simon DK, Simuni T, Poon C, Schiess MC, Chou K, Park A, Bhatti D, Peterson C, Criswell SR, Rosenthal L, Durphy J, Shill HA, Mehta SH, Ahmed A, Deik AF, Fang JY, Stover N, Zhang L, Dewey RB, Gerald A, Boyd JT, Houston E, Suski V, Mosovsky S, Cloud L, Shah BB, Saint-Hilaire M, James R, Zauber SE, Reich S, Shprecher D, Pahwa R, Langhammer A, LaFaver K, LeWitt PA, Kaminski P, Goudreau J, Russell D, Houghton DJ, Laroche A, Thomas K, McGraw M, Mari Z, Serrano C, Blindauer K, Rabin M, Kurlan R, Morgan JC, Soileau M, Ainslie M, Bodis-Wollner I, Schneider RB, Waters C, Ratel AS, Beck CA, Bolger P, Callahan KF, Crotty GF, Klements D, Kostrzebski M, McMahon GM, Pothier L, Waikar SS, Lang A, Mestre T

JAMA.. 2021 September 14326 (10):926-939. Epub 1900 01 01.

Digital Technology in Movement Disorders: Updates, Applications, and Challenges.

Adams JL, Lizarraga KJ, Waddell EM, Myers TL, Jensen-Roberts S, Modica JS, Schneider RB

Current neurology and neuroscience reports.. 2021 March 321 (4):16. Epub 03/03/2021.

A New Era: The Growth of Video-Based Visits for Remote Management of Persons with Parkinson's Disease.

Larson DN, Schneider RB, Simuni T

Journal of Parkinson's disease.. 2021 January 20 Epub 01/20/2021.

The Importance of Cross-Disciplinary Research: A Commentary on "Brainstem Pathologies Correlate With Depression and Psychosis in Parkinson's Disease".

Schneider RB, Richard IH

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.. 2021 January 19 Epub 01/19/2021.

Video-based Parkinson's disease assessments in a nationwide cohort of Fox Insight participants.

Myers TL, Tarolli CG, Adams JL, Barbano R, Cristina Gil-Díaz M, Spear KL, Lowell J, Daeschler M, Riley L, Amondikar N, Auinger P, Marras C, Tanner CM, Ray Dorsey E, Schneider RB

Clinical parkinsonism & related disorders.. 2021 4 :100094. Epub 05/24/2021.

Design of a virtual longitudinal observational study in Parkinson's disease (AT-HOME PD).

Schneider RB, Omberg L, Macklin EA, Daeschler M, Bataille L, Anthwal S, Myers TL, Baloga E, Duquette S, Snyder P, Amodeo K, Tarolli CG, Adams JL, Callahan KF, Gottesman J, Kopil CM, Lungu C, Ascherio A, Beck JC, Biglan K, Espay AJ, Tanner C, Oakes D, Shoulson I, Novak D, Kayson E, Ray Dorsey E, Mangravite L, Schwarzschild MA, Simuni T,

Annals of clinical and translational neurology.. 2020 December 22 Epub 12/22/2020.

Parkinson disease with mild cognitive impairment: Domain-specific cognitive complaints predict dementia.

Gasca-Salas C, Duff-Canning S, Armstrong MJ, Eslinger PJ, Schneider RB, Kennedy N, Chou KL, Persad C, Litvan I, Weintraub S, Marras C

Acta neurologica Scandinavica.. 2020 December 142 (6):585-596. Epub 08/16/2020.

A trial of buspirone for anxiety in Parkinson's disease: Safety and tolerability.

Schneider RB, Auinger P, Tarolli CG, Iourinets J, Gil-Díaz MC, Richard IH

Parkinsonism & related disorders.. 2020 October 1381 :69-74. Epub 10/13/2020.

Cognitive impairment in Parkinson's disease: Associations between subjective and objective cognitive decline in a large longitudinal study.

Mills KA, Schneider RB, Saint-Hilaire M, Ross GW, Hauser RA, Lang AE, Halverson MJ, Oakes D, Eberly S, Litvan I, Blindauer K, Aquino C, Simuni T, Marras C

Parkinsonism & related disorders.. 2020 September 2080 :127-132. Epub 09/20/2020.

Remote Administration of the MDS-UPDRS in the Time of COVID-19 and Beyond.

Schneider RB, Myers TL, Tarolli CG, Amodeo K, Adams JL, Jensen-Roberts S, Dorsey ER

Journal of Parkinson's disease.. 2020 July 15 Epub 07/15/2020.

A Virtual Cohort Study of Individuals at Genetic Risk for Parkinson's Disease: Study Protocol and Design.

Schneider RB, Myers TL, Rowbotham HM, Luff MK, Amodeo K, Sharma S, Wilson R, Jensen-Roberts S, Auinger P, McDermott MP, Alcalay RN, Biglan K, Kinel D, Tanner C, Winter-Evans R, Augustine EF, Cannon P, , Holloway RG, Dorsey ER

Journal of Parkinson's disease.. 2020 June 15 Epub 06/15/2020.

Telemedicine: A valuable tool in neurodegenerative diseases.

Adams JL, Myers TL, Waddell EM, Spear KL, Schneider RB

Current geriatrics reports.. 2020 June 9 (2):72-81. Epub 03/14/2020.

Deep Phenotyping of Parkinson's Disease.

Dorsey ER, Omberg L, Waddell E, Adams JL, Adams R, Ali MR, Amodeo K, Arky A, Augustine EF, Dinesh K, Hoque ME, Glidden AM, Jensen-Roberts S, Kabelac Z, Katabi D, Kieburtz K, Kinel DR, Little MA, Lizarraga KJ, Myers T, Riggare S, Rosero SZ, Saria S, Schifitto G, Schneider RB, Sharma G, Shoulson I, Stevenson EA, Tarolli CG, Luo J, McDermott MP

Journal of Parkinson's disease.. 2020 May 22 Epub 05/22/2020.

Acute readmission following deep brain stimulation surgery for Parkinson's disease: A nationwide analysis.

Schneider RB, Jimenez-Shahed J, Abraham DS, Thibault DP, Mantri S, Fullard M, Burack MA, Chou KL, Spindler M, Jermakowicz WJ, D'Haese PF, York MK, Kirk JC, Schwalb JM, Espay AJ, Shih LC, Simon DK, Hunter C, Crispo JAG, Willis AW,

Parkinsonism & related disorders.. 2019 December 19 Epub 12/19/2019.

Earlier Dopaminergic Treatment in Parkinson's Disease Is Not Associated With Improved Outcomes.

Schneider RB, Lu X, Biglan K, McDermott MP

Movement disorders clinical practice.. 2019 March 6 (3):222-226. Epub 01/28/2019.

Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.

Faust-Socher A, Duff-Canning S, Grabovsky A, Armstrong MJ, Rothberg B, Eslinger PJ, Meaney CA, Schneider RB, Tang-Wai DF, Fox SH, Zadikoff C, Kennedy N, Chou KL, Persad C, Litvan I, Mast BT, Gerstenecker AT, Weintraub S, Reginold W, Marras C

Dementia and geriatric cognitive disorders.. 2019 47 (4-6):187-197. Epub 07/17/2019.

Using Smartphones and Machine Learning to Quantify Parkinson Disease Severity: The Mobile Parkinson Disease Score.

Zhan A, Mohan S, Tarolli C, Schneider RB, Adams JL, Sharma S, Elson MJ, Spear KL, Glidden AM, Little MA, Terzis A, Dorsey ER, Saria S

JAMA neurology.. 2018 July 175 (7):876-880. Epub 1900 01 01.

Parkinson's disease psychosis: presentation, diagnosis and management.

Schneider RB, Iourinets J, Richard IH

Neurodegenerative disease management.. 2017 December 7 (6):365-376. Epub 11/21/2017.

The promise of telemedicine for chronic neurological disorders: the example of Parkinson's disease.

Schneider RB, Biglan KM

The Lancet. Neurology.. 2017 July 16 (7):541-551. Epub 05/26/2017.

Call to Caution with the Use of Atypical Antipsychotics for Treatment of Depression in Older Adults.

Amodeo K, Schneider RB, Hegeman Richard I

Geriatrics.. 2016 December 161 (4)Epub 12/16/2016.

The prevalence of nonmotor symptoms among SWEDD patients.

Schneider RB, Hegeman Richard I

Movement disorders : official journal of the Movement Disorder Society.. 2016 October 31 (10):1587-1588. Epub 1900 01 01.

Delineation of the movement disorders associated with FOXG1 mutations.

Papandreou A, Schneider RB, Augustine EF, Ng J, Mankad K, Meyer E, McTague A, Ngoh A, Hemingway C, Robinson R, Varadkar SM, Kinali M, Salpietro V, O'Driscoll MC, Basheer SN, Webster RI, Mohammad SS, Pula S, McGowan M, Trump N, Jenkins L, Elmslie F, Scott RH, Hurst JA, Perez-Duenas B, Paciorkowski AR, Kurian MA

Neurology.. 2016 May 1086 (19):1794-800. Epub 03/30/2016.

Pandemic influenza: antiviral preparedness and health care workers.

Schneider RB, Benitez JG, D'Angelo A, Tyo K

Disaster medicine and public health preparedness.. 2010 March 4 (1):55-61. Epub 1900 01 01.

Books

Cecil Essentials of Medicine (2022)

Chapter: Disorders of the Motor System

Authors: Ruth B Schneider, Adolfo Ramirez-Zamora, Christopher G Tarolli

Publisher: Elsevier, Inc 2022

Ratings & Reviews

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.